Posted On: 02/19/2015 9:27:17 PM
Post# of 30067

Re: Anaconda83 #16966
Very well said Ana. The biggest problem with this stock is the lack of valuation. How much are we charging for each test? Is their estimate for Lympro still just a million? I know dilution and the otc board hurts this stock as well but with no real numbers its hard to put a real value.
WD
WD

